WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: LUCENTIS RANIBIZUMAB INJECTION

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on LUCENTIS RANIBIZUMAB INJECTION

Mark Identification

Proof of use for LUCENTIS RANIBIZUMAB INJECTION

We do not have any records of a proof of use for LUCENTIS RANIBIZUMAB INJECTION at this moment.

Click here to add a proof of use for LUCENTIS RANIBIZUMAB INJECTION

Possible trademark infringements of LUCENTIS RANIBIZUMAB INJECTION

Basic Information about LUCENTIS RANIBIZUMAB INJECTION

Serial Number
78914719
Filing Date
22 Jun 2006
Registration Number
3386828
Registration Date
19 Feb 2008
Mark Drawing Code
3

Classifications

Declare the trademark use of LUCENTIS RANIBIZUMAB INJECTION on the blockchain with WikiTrademarks.io.

First use of LUCENTIS RANIBIZUMAB INJECTION anywhere
LUCENTIS RANIBIZUMAB INJECTION was first used on 30 Jun 2006 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns LUCENTIS RANIBIZUMAB INJECTION?

1. Genentech, Inc. SOUTH SAN FRANCISCO CA

2. Genentech, Inc. South San Francisco CA

3. Genentech, Inc. South San Francisco CA

Correspondent

Andre Krammer
1 DNA Way
South San Francisco CA 94080

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on LUCENTIS RANIBIZUMAB INJECTION